Nov 03, 2022 / 08:30PM GMT
Operator
Good afternoon. My name is Jason, and I'll be your conference operator today. At this time, I would like to welcome everyone to Karyopharm Therapeutics Third Quarter 2020 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request. (Operator Instructions)
I would now like to turn the call over to Elhan Webb, Senior Vice President of Investor Relations.
Elhan Webb - Karyopharm Therapeutics Inc. - SVP of IR
Thank you, operator, and thank you all for joining us on today's conference call to discuss the Karyopharm's Third Quarter 2022 financial results and recent company progress. Today, I'm joined by Richard Paulson, President and CEO; Sohanya Cheng, Chief Commercial Officer; Dr. Reshma Rangwala, Chief Medical Officer; and Mike Mason, Chief Financial Officer. Today, we issued a press release detailing Karyopharm's financial results for the third quarter 2020. This release, along with a slide presentation that we will reference during today's call are
Q3 2022 Karyopharm Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot